Airway diseases

The airway is composed of an upper and a lower airway.</p

Akuttan Kroniğe Pulmoner Tromboemboli

Pulmoner emboli (PE), tanı yöntemlerinin daha fazla kullanılmasına bağlı olarak sıklığı giderek artan, mortalitesi yüksek bir durumdur. Daha etkili tedaviler ve rehberlere daha iyi uyum sağlanması, son zamanlarda PE'nin prognozu üzerinde önemli bir olumlu etki yapmıştır. Son yıllarda gereksiz test kullanımının önüne geçmek için klinik skorlama yöntemleri doğrulanmış ve kullanılmaya başlanmıştır. Fibrin yıkım ürünü olan D-dimer, PE şüpheli birçok hasta için ilk başvurulan test olup klinik olasılık düşük olan hastalarda negatif prediktif değeri yüksektir. Kardiyak biyobelirteçler de mortalite riski belirlemede ve hastanın hospitalize olup olmaması kararında önem taşımaktadır. Kardiyak fonksiyonları değerlendirmek için transtorasik ekokardiyografi ve kardiyak biyobelirteçlerin yanında, BTPA'da sağ ventrikül işlevi gösteren bulgular da yol göstericidir.</p

Intravascular coil migration to bronchus: review of the literature with two case reports

Pulmonary vascular abnormalities are important causes of hemoptysis. Arteriovenous malformation (AVM), pulmonary arterial aneurysms or invasion of the pulmonary arterial structures by the tumor may cause hemoptysis. Pulmonary artery aneurysms (PAA) are an infrequent disease of the pulmonary vasculature. Endovascular coil application is a convenient treatment option for the treatment of hemoptysis due to vascular anomalies. The migration of intravascular coil to another tissue is a rare complication. To review this extremely rare complication, herein we report two unusual cases who had pulmonary artery aneurysm and who had hemoptysis due to tumor invasion to pulmonary artery, initially treated with endovascular coil successfully. In both cases endovascular coil was migrated to the bronchus subsequently. Lobectomy may be performed in such cases with coil migration into the bronchus or conservative therapy with follow-up chest imaging may be a suitable treatment option for selected patients. The choice of treatment should be made individually for each patient considering the characteristics of the patients. In patients with coils, the biopsy can lead to massive hemorrhages that are fatal

Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide

In December 2019, coronavirus disease 2019 (COVID-19) emerged in Wuhan and rapidly spread throughout China. Since the outbreak of the pandemic, in addition to the well-known COVID-19 symptoms, various neurological symptoms have been also described in patients with COVID-19. Here, we report an unusual presentation of COVID-19 infection in a teriflunomide-treated individual with multiple sclerosis (MS) who did not interrupt teriflunomide treatment during the infection. The course of the infection was mild in this case as in other reported teriflunomide-treated individuals with COVID-19. COVID-19's presentation may be unusual in people with MS (pwMS). It can also be concluded that teriflunomide may be considered a safe disease-modifying treatment option during the pandemic